How to Document CBT for Insomnia (CBT-I) Sessions

Why CBT-I Documentation Has Its Own Requirements

Most outpatient therapy notes document a presenting problem, the interventions used, the client's response, and the plan for next session. A DAP or SOAP note built for that pattern handles the majority of therapy modalities reasonably well.

Cognitive Behavioral Therapy for Insomnia (CBT-I) is a structured, multi-component protocol that generates a specific category of data absent from most therapy notes: nightly sleep parameter tracking, calculated sleep metrics, behavioral prescription changes calibrated session by session, and a longitudinal trajectory of improvement measured against validated scales. A generic note that says "sleep hygiene education provided, client tolerating well" misses almost everything clinically relevant about what happened in the session.

The documentation challenge in CBT-I is not complexity for its own sake. It is that the protocol is data-driven. The behavioral prescriptions you give a client in Session 3 depend on sleep diary data from the prior week. Your next session's modifications depend on what happened with those prescriptions. If that chain is not traceable in your notes, you cannot justify continued treatment, hand the case to a colleague coherently, or demonstrate to an insurer or supervisor that treatment decisions were evidence-based.

This guide covers the core data points every CBT-I note must capture, session-by-session documentation structure across the typical 4-to-8-session protocol, how to integrate sleep diary data, how to document sleep restriction therapy (SRT) and stimulus control instructions (SCI) changes, which validated outcome measures to use and how to record them, how to document hypnotic medication taper coordination, and how to modify documentation when comorbid conditions complicate the picture.

The Core Data Points That Make CBT-I Notes Different

Sleep Diary Data Is a Clinical Record, Not an Attachment

Sleep diaries are the primary data source for CBT-I. They capture nightly estimates of time in bed (TIB), sleep onset latency (SOL), number and duration of awakenings, early morning awakening, and total sleep time (TST). Many therapists treat the diary as a handout the client brings to session, review it verbally, and then write a note that says "reviewed sleep diary."

That approach creates a documentation gap. The diary data drives your clinical decisions. If you adjusted the sleep restriction window this week because sleep efficiency improved from 72% to 84%, that logic needs to appear in the note, not just the decision. When a reviewer or a supervisee reads your chart, the reasoning should be self-evident.

At a minimum, extract the following weekly averages into your notes:

• Time in Bed (TIB): prescribed and actual
• Total Sleep Time (TST): average across the week
• Sleep Onset Latency (SOL): average minutes to fall asleep
• Wake After Sleep Onset (WASO): average minutes of nighttime waking
• Early Morning Awakening (EMA): if present, how many minutes before intended wake time
• Sleep Efficiency (SE): calculated as (TST / TIB) x 100

These are objective-tier data even though they rely on self-report estimates. Treat them accordingly in your notes: record them, trend them across sessions, and use them to justify your interventions.

Sleep Efficiency Is Your Primary Progress Metric

Sleep efficiency (SE) is the ratio of time actually asleep to time spent in bed, expressed as a percentage. An SE below 85% is clinically significant for adults. CBT-I, particularly sleep restriction therapy, uses SE as the decision rule for adjusting the sleep window: if SE is 85% or above for the week, the sleep window expands by 15 to 30 minutes; if SE is below 80%, it contracts; between 80 and 85%, it holds.

Your notes need to show this calculation explicitly, not just the outcome. "SE 88%, sleep window expanded by 15 minutes" is auditable. "Client doing better, extended sleep window" is not.

Behavioral Prescriptions Are Clinical Orders

Every session ends with specific behavioral prescriptions: a prescribed sleep window (bed time and wake time), stimulus control instructions, a plan for naps (typically restricted or eliminated), and cognitive or arousal-reduction techniques to practice between sessions. These function the same way medication prescriptions do: they need to be documented, and the next session note needs to show whether the client followed them and what the result was.

Session-by-Session Documentation Structure

CBT-I protocols typically run 4 to 8 sessions. The structure below reflects the standard protocol used in research and clinical practice, adapted for individual outpatient delivery.

Session 1: Assessment and Psychoeducation

The first session establishes baseline, obtains a full sleep history, rules out contraindications, and introduces the CBT-I rationale. The clinical note for Session 1 functions like an intake combined with a treatment planning document.

What to document:

• Chief sleep complaint, onset, duration, and prior treatment history (including hypnotic medications and any response to them)
• Sleep history: typical sleep pattern across weekdays and weekends, occupational schedule, shift work status, napping habits
• Two-week sleep diary review: if a prospective diary was completed pre-treatment, extract averages; if not, obtain retrospective estimates and note that a prospective diary begins this week
• Contraindications assessed and outcome: obstructive sleep apnea (OSA) symptoms (snoring, witnessed apneas, excessive daytime sleepiness disproportionate to insomnia severity, Epworth Sleepiness Scale score), restless legs syndrome (RLS), bipolar disorder (sleep restriction is relatively contraindicated), seizure disorder, occupational safety concerns with sleep deprivation, or active psychosis
• Insomnia Severity Index (ISI) baseline score with item-level notation of severity profile
• Pittsburgh Sleep Quality Index (PSQI) baseline score and global score with subscale pattern
• Psychoeducation topics covered: two-process model of sleep (homeostatic drive and circadian rhythm), how hyperarousal perpetuates insomnia, rationale for sleep restriction, rationale for stimulus control
• Sleep diary instructions given; format provided
• Plan for Session 2

A concrete documentation example: "Client is a 44-year-old woman (she/her) presenting with a seven-year history of chronic insomnia disorder (F51.01) characterized by difficulty maintaining sleep and early morning awakening averaging 45 minutes before desired wake time. ISI baseline: 20/28 (severe). PSQI global score: 14 (significantly disrupted sleep). Sleep history notable for retirement-related schedule change four years ago eliminating occupational anchors; current average TIB 8.5 hours, estimated TST 5.0 hours, calculated SE 59%. No OSA symptoms reported; no RLS features. Epworth Sleepiness Scale: 7/24 (normal). Bipolar disorder screened and ruled out. No occupational safety concerns. Psychoeducation provided on two-process sleep model and hyperarousal cycle. CBT-I rationale accepted by client with good understanding. Prospective sleep diary begun this week. No medications currently for sleep. Session 2 to review diary data and introduce sleep restriction."

Session 2: Sleep Restriction and Stimulus Control Introduction

This is typically the most demanding session to document well because it involves a behavioral prescription derived from calculations, and the rationale for those calculations needs to appear in the record.

What to document:

• Sleep diary data from past week: TIB (actual average), TST (average), SOL, WASO, SE (calculated), EMA if present
• Prescribed sleep window: bed time and wake time, derived from diary data (initial TIB prescription is typically set at TST average with a minimum floor of 5.5 hours, regardless of actual TIB)
• SE used as decision basis: note the calculation and the threshold applied
• Stimulus control instructions provided: list each instruction explicitly, not just "SCI reviewed"
• Any modifications to standard SCI made and rationale (for example, if the client lives alone and safety concerns about getting out of bed in the dark were discussed)
• Psychoeducation on short-term sleep deprivation as mechanism of treatment: why SE must drop before it rises
• Client's reaction and identified barriers; plan to address them
• Cognitive restructuring techniques introduced if time permits (often deferred to Session 3 when SRT is demanding)
• Behavioral prescriptions for the coming week, stated precisely

Standard stimulus control instructions to document individually or by checklist:

1. Use the bed only for sleep and sex
2. If unable to sleep after approximately 20 minutes, leave the bed and return only when sleepy
3. Keep a consistent wake time every day, including weekends
4. Avoid napping (or restrict to a brief early-afternoon nap if fatigue is severe, with specific parameters)
5. Go to bed only when sleepy, not at a fixed time dictated by habit

Documentation example for Session 2: "Sleep diary Week 1 averages: TIB 8.2 hours, TST 4.9 hours, SOL 22 minutes, WASO 65 minutes, SE 60%, EMA 38 minutes. Calculated initial sleep window: 11:30 PM to 6:00 AM (6.5 hours, anchored to client's preferred wake time). Rationale: TST average 4.9 hours; prescribed window set 90 minutes above TST average with 6.5-hour minimum floor, anchored to fixed 6:00 AM wake. Stimulus control instructions reviewed individually. Client identified barrier: does not want to leave bed in winter when floor is cold; problem-solved by placing slippers and robe bedside. Barrier two: uses phone in bed to watch streaming content to fall asleep; plan to charge phone in kitchen starting tonight. Behavioral prescription: wake time 6:00 AM daily including weekends; bed time no earlier than 11:30 PM; no napping; phone out of bedroom. Client verbalized understanding and committed to full week trial. Session 3 to review diary data, calculate SE, and adjust window."

Session 3: First Sleep Window Adjustment

The third session is the pivot point of CBT-I. For most clients, Week 2 brings a significant spike in daytime fatigue and a modest but measurable improvement in SE. Documenting this transition carefully sets up the rest of the protocol.

What to document:

• Week 2 diary averages with SE calculation
• SE compared to threshold: if SE is 85% or above, expand window 15 to 30 minutes; 80 to 84%, hold; below 80%, assess adherence before contracting
• Whether window was adjusted, held, or contracted, with explicit SE-based rationale
• Adherence assessment: which prescriptions were followed, which were not, clinical significance of gaps
• Side effects of sleep restriction: daytime sleepiness severity, mood effects, occupational or driving safety (Epworth re-check if indicated), any episodes of unsafe drowsiness
• Cognitive restructuring content introduced or continued: identify the core dysfunctional beliefs about sleep being targeted (examples: catastrophic beliefs about the consequences of poor sleep, rigid standards about required sleep duration, misattributions of daytime performance deficits to prior night's sleep)
• Stimulus control adherence review: document each instruction individually if possible
• Updated prescription for Week 3

Documentation example: "Week 2 diary averages: TIB 6.5 hours (prescribed), TST 5.6 hours, SOL 14 minutes, WASO 30 minutes, SE 86%. SE exceeds 85% threshold. Sleep window expanded by 15 minutes: 11:15 PM to 6:00 AM (6 hours 45 minutes). Client reports significantly increased daytime fatigue days 3 and 4; resolved partially by Day 6. No driving safety concerns; Epworth 8/24. Stimulus control adherence: phone removed from bedroom 5 of 7 nights; bed used for sleep only 6 of 7 nights (one exception: fell asleep watching television in bed, self-corrected to chair). Cognitive restructuring introduced: client holds belief 'I need 8 hours to function the next day.' Examined evidence base; reviewed sleep science data on TST variability and functional resilience. Assignment: track next-day functioning independent of prior night's TST and compare at Session 4. Week 3 prescription: wake time 6:00 AM, bed time 11:15 PM, no napping, phone in kitchen."

Sessions 4 through 6: Window Titration and Cognitive Work

This phase repeats the assessment-calculate-adjust cycle while deepening the cognitive component of treatment. The documentation pattern is consistent across these sessions.

What to document in each session:

• Weekly diary averages and SE calculation, compared to prior weeks
• Window adjustment decision with explicit SE rationale
• Cognitive restructuring content: which belief or thought pattern was targeted, what restructuring technique was used (Socratic questioning, behavioral experiment design, decatastrophizing, or thought records), and the client's engagement and emerging cognitive shift
• Sleep-related safety behaviors identified and addressed: checking the clock, calculating sleep hours, excessive time in bed to compensate, rigid pre-sleep routines maintained out of anxiety
• Progress toward treatment goals: qualitative client report of daytime functioning, validated measure scores if re-administered (typically ISI and PSQI at mid-protocol)
• Any complications arising: comorbid condition flare, medication changes, acute life stressors, poor adherence with specific barriers identified

Mid-protocol outcome measure documentation: "Session 4, Week 4. ISI re-administration: score 11/28 (subthreshold insomnia). PSQI global score: 9. Improvement from baseline ISI 20, PSQI 14. Client reports sustained improvement in sleep maintenance but continued EMA. Sleep diary: TIB 7.2 hours, TST 6.3 hours, SE 88%. Window expanded to 10:45 PM to 6:00 AM (7 hours 15 minutes). Cognitive restructuring this session: addressed catastrophic belief 'If I don't sleep tonight, tomorrow will be ruined.' Behavioral experiment assigned in Session 3 (track next-day functioning): client brought completed log showing variable correlation between TST and perceived next-day performance; three of seven days, low TST did not produce expected performance deficit. Reviewed data collaboratively. Client identified emerging belief: 'My functioning is more resilient than I assumed.' Stimulus control adherence strong. EMA addressed: clock-checking behavior identified as primary maintenance factor; plan to cover clock face and remove from visual field."

Session 7 and 8: Consolidation, Relapse Prevention, and Discharge

The final sessions shift from active titration to consolidation and relapse prevention. Documentation here needs to establish the endpoint of active treatment and set up a durable maintenance plan.

What to document:

• Final diary averages and SE at treatment close
• Final ISI and PSQI scores with comparison to baseline
• Sleep window consolidation: documenting the settled sleep window the client will maintain post-treatment
• Relapse prevention plan: what early warning signs the client will monitor, what self-directed steps to take if insomnia recurs (brief return to sleep restriction, re-initiation of stimulus control), and under what circumstances the client should seek additional contact
• Summary of gains: functional improvements beyond sleep metrics (mood, daytime energy, occupational performance, social engagement)
• Discharge rationale: criteria met for treatment completion (SE above 85% for at least two consecutive weeks, ISI below 8 or clinically significant reduction, client-reported confidence in self-management)
• Any recommendation for booster sessions with criteria

Hypnotic Medication Taper Coordination

Many clients entering CBT-I are taking hypnotic medications: benzodiazepine receptor agonists such as zolpidem or eszopiclone, or other sedating agents prescribed for sleep. Coordination with the prescribing provider is a clinical responsibility, and the documentation requirements are specific.

What to document:

• Medication name, dose, and frequency at treatment outset; source of information (client self-report, pharmacy printout, prescriber note)
• Prescriber's name and whether they have been notified of CBT-I initiation (if the client has consented to coordination)
• Taper plan: whether tapering is occurring concurrently with CBT-I, planned taper schedule if applicable, and whether the taper is being managed by the prescriber or agreed jointly
• Client's ambivalence about tapering, if present: normalize that the medication may feel necessary before SE improves; document the clinical rationale offered
• Night-by-night medication use as captured in the sleep diary, if the client is tracking this
• Any taper-related sleep disruption and how it was addressed in treatment
• Any communication with the prescriber: dates, method (phone, secure message, in-person), content of communication, prescriber's response

Example documentation: "Client currently taking zolpidem 10 mg nightly for approximately three years. Prescribing physician is Dr. M. Torres. Client has provided signed authorization for treatment coordination. Contact made with Dr. Torres via phone on Session 2 date; notified of CBT-I initiation. Dr. Torres confirmed willingness to support taper concurrent with CBT-I once SE exceeds 85% for two consecutive weeks. Taper plan: reduce zolpidem to 5 mg nightly at that threshold, then further reduction at clinician discretion in subsequent weeks. Client ambivalent about tapering; concerned about rebound insomnia. Psychoeducation provided on distinction between dependence and pharmacological rebound, and on evidence base showing CBT-I outcomes superior to medication in the long term. Client agreed to defer medication discussion until Week 4."

If no prescriber coordination occurs because the client declines to authorize it, document that declination and the informed consent conversation you had about the clinical implications.

Validated Outcome Measures: ISI and PSQI

Insomnia Severity Index

The Insomnia Severity Index (ISI) is a seven-item self-report scale measuring insomnia severity over the prior two weeks. Scores range from 0 to 28. Clinical thresholds: 0 to 7 = no clinically significant insomnia; 8 to 14 = subthreshold insomnia; 15 to 21 = moderate insomnia; 22 to 28 = severe insomnia.

Administer at baseline (Session 1), at mid-protocol (typically Session 4), and at treatment close. In your notes, record the total score and the threshold category, and note the clinical meaning of score movement. A drop from 20 to 11 means the client has moved from the moderate-to-severe range into subthreshold insomnia, which is a clinically meaningful shift even if complete remission has not occurred.

Pittsburgh Sleep Quality Index

The Pittsburgh Sleep Quality Index (PSQI) is a 19-item self-report measure covering seven subscales: subjective sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, use of sleep medications, and daytime dysfunction. Global scores range from 0 to 21; scores above 5 indicate poor sleep quality. Subscale scores allow you to track where improvement is and is not occurring.

Administer at baseline and at treatment close, with optional mid-protocol re-administration. Document total score and subscale profile, not just the global score. A client whose global score drops from 14 to 8 but whose sleep medication subscale remains high is communicating something different clinically from a client whose subscale profile is uniformly improved.

Recording Outcomes in Your Notes

Avoid recording scores in isolation. Every outcome measure entry should include the score, the threshold category, a comparison to the prior administration, and a brief clinical interpretation.

Example: "ISI Session 6: 8/28 (subthreshold insomnia). Baseline ISI 20, Session 4 ISI 11. Sustained downward trajectory across three administrations. Client reports subjective sense of confidence in sleep that was absent at baseline. PSQI Session 6: global score 7. Subscale scores: sleep efficiency 1, sleep duration 1, daytime dysfunction 1. Improvement across all subscales compared to baseline global 14. Medication subscale remains 2 (still using zolpidem 5 mg three nights per week per taper plan with Dr. Torres). This is expected given active taper and does not reflect deterioration in sleep quality."

Documenting Treatment Modifications for Comorbid Conditions

CBT-I is frequently delivered to clients with comorbid psychiatric or medical conditions. Those comorbidities change what you can prescribe, how aggressively you can implement sleep restriction, and what you need to monitor. The documentation needs to reflect those modifications explicitly, not just note that a comorbidity exists.

Major Depressive Disorder

Sleep restriction can transiently worsen depressive mood and energy, particularly in the first two weeks of active restriction. Document: the baseline mood rating (PHQ-9 score at Session 1 recommended), the decision to monitor mood throughout the protocol, and your plan for if mood worsens significantly (slowing the pace of restriction, coordinating with a prescriber if antidepressant adjustment is being managed elsewhere). Capture PHQ-9 scores at each session during the active restriction phase.

Example: "PHQ-9 baseline: 13 (moderate depression). Decision made to implement CBT-I with close mood monitoring given active depressive episode. Sleep restriction initial window set conservatively at 6.0 hours rather than strict TST average, to limit sleep deprivation burden. PHQ-9 to be administered at every session through Session 5. Coordinating with prescribing psychiatrist Dr. J. Reyes; communication documented separately."

Anxiety Disorders

Many clients with comorbid generalized anxiety disorder (GAD) or panic disorder experience heightened arousal at bedtime that is not sleep-specific. Document which anxiety symptoms overlap with insomnia symptoms (hyperarousal, rumination, worry), and how treatment targets both. Relaxation techniques and cognitive restructuring may address both presenting concerns simultaneously; document which concern each technique is targeting.

Chronic Pain

Clients with comorbid chronic pain conditions face sleep disruption from pain-related arousals that are mechanistically distinct from hyperarousal-driven insomnia. Sleep restriction is appropriate but may need slower titration. Document: pain intensity ratings at each session (NRS-11 or equivalent), the decision to titrate more gradually with rationale, and whether pain management is being addressed concurrently. Note whether pain-related awakenings are captured in the WASO data and acknowledged as distinct from arousal-driven awakenings.

Bipolar Disorder

CBT-I with standard sleep restriction is relatively contraindicated in bipolar disorder because sleep deprivation can precipitate hypomanic or manic episodes. If you are delivering modified CBT-I to a client with bipolar disorder, document: consultation with the treating psychiatrist, the specific protocol modifications made (typically eliminating sleep restriction and focusing on stimulus control and sleep scheduling without restriction), mood monitoring plan, and the criteria that would indicate pausing treatment.

Common Documentation Mistakes

Recording Diary Data Verbatim Without Analysis

Many therapists copy a week's worth of nightly diary entries directly into the note. This generates documentation that is long and cluttered without being useful. What belongs in the note is the weekly averages and the calculated SE, not seven rows of raw data. Attach or reference the diary if needed; extract the clinically relevant summary in the note.

Omitting the SE Calculation

"Client's sleep improved, extended sleep window by 15 minutes" tells no one anything auditable. Document the SE percentage, confirm it against the threshold, and then note the window adjustment. The calculation is the clinical reasoning.

Vague Prescription Documentation

"Client will continue working on sleep hygiene" is not a behavioral prescription. Write the bed time, the wake time, the nap policy, and any specific behavioral targets for the week. Precision matters because these prescriptions are what the next session's review depends on.

Missing Contraindication Screening

Session 1 notes that do not document OSA screening, safety assessment for sleep restriction, and comorbidity review leave a significant gap. A client who falls asleep driving in Week 2 while underslept from sleep restriction is a documentation and liability problem if your initial assessment note contains no record that occupational and driving safety were considered.

Treating ISI and PSQI as Paperwork

Outcome measures recorded in a chart and never referenced again serve no clinical or documentation function. Every time you administer the ISI or PSQI, the score needs to be interpreted in the note and compared to the prior administration. That comparison is your evidence of progress and your justification for continuing, modifying, or ending treatment.

Skipping Relapse Prevention Documentation at Discharge

Many clients with insomnia disorder experience recurrence, particularly during periods of elevated stress. A discharge note that does not capture the relapse prevention plan, the criteria for self-directed re-implementation of CBT-I techniques, and the threshold for seeking additional sessions is an incomplete discharge note for this particular disorder.

A Note on Workflow

CBT-I generates more structured numeric data per session than most outpatient modalities. Keeping a session template with dedicated fields for weekly diary averages, SE calculation, window adjustment decision, and outcome measure scores means you are not reconstructing these figures from memory at the end of the day.

NotuDocs supports custom session templates with structured fields, so your CBT-I notes capture diary averages, SE, prescription changes, and outcome measure scores in the same location every session. The structure is yours to configure; the clinical content stays consistent across the protocol.

CBT-I Session Documentation Checklist

Session 1: Assessment and Baseline

• Sleep complaint onset, duration, and prior treatment history documented
• Sleep history: schedule, napping, weekday and weekend variability
• Contraindications screened: OSA symptoms, RLS, bipolar disorder, seizure disorder, occupational/driving safety
• ISI baseline score documented with threshold category
• PSQI baseline global score and subscale profile documented
• Sleep diary instructions given; prospective diary begun
• Psychoeducation topics listed: two-process model, hyperarousal cycle, CBT-I rationale
• Medications for sleep documented: name, dose, frequency

Session 2: Sleep Restriction and Stimulus Control Introduction

• Week 1 diary averages: TIB, TST, SOL, WASO, EMA
• SE calculated and documented (TST / TIB x 100)
• Prescribed sleep window documented: bed time and wake time with derivation rationale
• Stimulus control instructions documented individually (all five)
• Barriers to adherence identified and problem-solved
• Psychoeducation on short-term sleep deprivation as mechanism documented
• Behavioral prescription for Week 2 stated precisely

Each Subsequent Session (3 through 6)

• Weekly diary averages and SE calculation documented
• SE compared to threshold (below 80%, hold 80-84%, expand 85%+); decision stated
• Sleep window adjustment documented with new bed time and wake time
• Stimulus control adherence reviewed by instruction
• Daytime sleepiness and safety monitored; Epworth re-administered if indicated
• Cognitive restructuring content: belief targeted, technique used, client's response
• Sleep-related safety behaviors identified and addressed if present
• Medication use and taper status noted if applicable
• Behavioral prescription for next week stated precisely

Outcome Measures

• ISI administered at Session 1 (baseline), Session 4 (mid-protocol), and Session 7/8 (close)
• PSQI administered at Session 1 and Session 7/8; mid-protocol optional
• Every score documented with threshold category, comparison to prior, and clinical interpretation

Hypnotic Medication Coordination

• Medication name, dose, frequency documented at Session 1
• Prescriber identified; coordination status documented
• Authorization for coordination noted if applicable
• Taper plan documented with threshold criteria and schedule
• Client ambivalence about taper addressed and documented
• Any prescriber communication documented with date, method, content, and response

Comorbid Condition Modifications

• Comorbid conditions identified and clinical implications for CBT-I noted
• Protocol modifications documented with rationale
• Additional monitoring measures in place (PHQ-9 for MDD, pain ratings for chronic pain)
• Coordination with other treating providers documented where applicable

Sessions 7 and 8: Consolidation and Discharge

• Final diary averages and SE documented
• Final ISI and PSQI scores with comparison to baseline
• Consolidated sleep window documented
• Relapse prevention plan documented: early warning signs, self-directed steps, threshold for re-contact
• Functional gains documented beyond sleep metrics
• Discharge rationale: criteria met for treatment completion

---

CBT-I is one of the most evidence-based treatments available for chronic insomnia, with outcomes that rival or exceed pharmacotherapy in most research comparisons. The protocol's structure is a documentation asset: when you capture sleep diary data systematically, calculate SE consistently, and link every window adjustment to a threshold decision, your notes tell a coherent clinical story that any reviewer or colleague can follow. That traceability is what transforms a collection of session notes into a treatment record.

Related reading: How to Document Therapy Sessions Using Standardized Outcome Measures, How to Document Psychiatric Medication Management Visits, and How Therapist Documentation Burnout Affects Practice.